Close

Deutsche Bank Upgrades Ligand Pharma (LGND) to Hold

September 7, 2016 7:20 AM EDT Send to a Friend
Deutsche Bank upgraded Ligand Pharma (NASDAQ: LGND) from Sell to Hold with a price target of $105.00 (from $110.00). Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login